| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/05/1991 | CA1279868C 3-(substituted)propenylaminothiazolylcephalosporanic acids and esters thereof |
| 02/05/1991 | CA1279824C Pharmaceutical and dietary composition containing -linolenic acid |
| 02/05/1991 | CA1279823C Pharmaceutical and dietary composition for pre-menstrual syndrome |
| 02/05/1991 | CA1279822C Biologically-active copolymers |
| 02/05/1991 | CA1279821C Composition for minimizing scarring in a patient suffering from burns |
| 02/04/1991 | WO1991001732A1 Slowly dissociating (tight binding) dopamine, serotonin or norepinephrine reuptake inhibitors as cocaine, amphetamine and phencyclidine antagonists |
| 02/04/1991 | WO1991001718A1 Method of photostabilizing eyewash and photostabilized eyewash |
| 02/04/1991 | CA2064574A1 Slowly dissociating (tight binding) dopamine, serotonin or norepinephrine reuptake inhibitors as cocaine, amphetamine and phencyclidine antagonists |
| 02/04/1991 | CA2022423A1 Hmg-coa reductase-inhibiting imino-substituted pyridines |
| 02/04/1991 | CA2021926A1 Heterocyclic compounds |
| 02/03/1991 | CA2022513A1 Formulations of phenytoin sodium for intravenous administration |
| 02/03/1991 | CA2022511A1 4-(n-substituted amino)-2-butynyl-1-carbamates and thiocarbamates and derivatives thereof as centrally acting muscarinic agents |
| 02/03/1991 | CA2022510A1 4-(n-substituted amino)-2-butynyl-1-ureas and thioureas and derivatives thereof as centrally acting muscarinic agents |
| 02/03/1991 | CA2022507A1 Process for preparing monobactames and their intermediate product |
| 02/03/1991 | CA2022422A1 Method and preparation for reducing risk of myocardial infarction |
| 02/03/1991 | CA2022382A1 Piperidylthiocarbapenem derivatives |
| 02/02/1991 | CA2022380A1 Medicaments |
| 02/02/1991 | CA2022379A1 Medicaments |
| 02/02/1991 | CA2022311A1 Copper radiosensitizers |
| 02/01/1991 | WO1991001963A2 Use of sebacic acid and derivatives thereof in enteral and parenteral nutrition and pharmaceutical compositions containing said compounds |
| 02/01/1991 | WO1991001761A1 Shelf stable aspirin solutions |
| 02/01/1991 | WO1991001728A1 Carnitine supplemented finishing pig diet |
| 02/01/1991 | WO1991001725A1 A NOVEL USE OF β-RECEPTOR BLOCKING AGENTS FOR TREATMENT OF MENIERES' DISEASE |
| 02/01/1991 | WO1991001717A1 A podophyllotoxin preparation containing triglycerides |
| 02/01/1991 | CA2064035A1 Shelf stable aspirin solutions |
| 02/01/1991 | CA2022236A1 Coumarin derivatives, their preparation and their use in the treatment of cerebrovascular disorders |
| 02/01/1991 | CA2022118A1 4-(2-methyl-2-hydroxypropylamino)-5,6-dihydrothieno-[2,3-b] thiopyran-2-sulfonamide-7,7-dioxide |
| 02/01/1991 | CA2022117A1 Hmg-coa synthase inhibitors |
| 02/01/1991 | CA2022116A1 Imidazole compounds and their use as transglutaminase inhibitors |
| 02/01/1991 | CA2022115A1 Imidazole compounds and their use as transglutaminase inhibitors |
| 02/01/1991 | CA2022114A1 Imidazole compounds and their use as transglutaminase inhibitors |
| 02/01/1991 | CA2022113A1 Avermectin derivatives |
| 02/01/1991 | CA2022112A1 Certain imidazole compounds as transglutaminase inhibitors |
| 02/01/1991 | CA2022110A1 Azole compounds and their use as transglutaminase inhibitors |
| 02/01/1991 | CA2022021A1 Method of resolving cis 3-amino-4-(2-(2-furyl)eth-1-yl)-1-methoxycarbonylmethyl- azetidin-2-one |
| 01/31/1991 | DE4020511A1 Medicaments for treating e.g. hypercalcaemia - contg. 24,25-di:hydroxy-cholecalciferol together with sesame oil for improved stability |
| 01/31/1991 | DE3925252A1 Kombinationspraeparat aus gallopamil und xipamid Kombinationspraeparat of gallopamil and xipamide |
| 01/31/1991 | DE3924570A1 Pharmazeutische zubereitung zur rektalen verabreichung Pharmaceutical preparation for rectal administration- |
| 01/31/1991 | DE3924424A1 Nucleosid-derivate, verfahren zu deren herstellung, deren verwendung als arzneimittel sowie deren verwendung bei der nucleinsaeure-sequenzierung Nucleoside derivatives, processes for their preparation, their use as medicaments and to their use in nucleic acid sequencing |
| 01/31/1991 | CA2000369A1 Topically active steroidal anti-inflammatory agents |
| 01/30/1991 | EP0410958A1 Process to prepare stable injectable compositions |
| 01/30/1991 | EP0410953A2 Piperidine compounds with glycosidase inhibition activity |
| 01/30/1991 | EP0410883A2 Di-lysogangliosides derivatives |
| 01/30/1991 | EP0410881A2 Semisynthetic ganglioside analogues |
| 01/30/1991 | EP0410834A1 Medicaments containing 4,1,2-Benzoxadiazine derivatives, new derivatives and processes for their preparation |
| 01/30/1991 | EP0410801A2 Intraocular pressure reducing 9,15-diacyl prostaglandins |
| 01/30/1991 | EP0410787A2 Intraocular pressure reducing 9,11-diacyl prostaglandins |
| 01/30/1991 | EP0410786A1 Intraocular pressure reducing 11,15-diacyl prostaglandins |
| 01/30/1991 | EP0410785A2 Intraocular pressure reducing 11-acyl prostaglandins |
| 01/30/1991 | EP0410762A1 Naphthyridine derivatives |
| 01/30/1991 | EP0410749A2 Anthocyanidins for the treatment of ophthalmic diseases |
| 01/30/1991 | EP0410742A1 Phenylethenyl compounds having retinoid-like activity |
| 01/30/1991 | EP0410661A2 Bicyclic derivatives |
| 01/30/1991 | EP0410660A1 Cyclopentane derivatives |
| 01/30/1991 | EP0410652A2 Use of 15-keto-prostanoic acid derivatives in the manufacture of a medicament for improvement of excretion of potassium ion |
| 01/30/1991 | EP0410646A2 Treatment of hyperlipidemia with 15-keto-prostaglandin compounds |
| 01/30/1991 | EP0410641A2 Dopamine agonists |
| 01/30/1991 | EP0410615A1 Antiparasitic agent |
| 01/30/1991 | EP0410554A2 14,17-Alpha-ethano- and ethano-estratrienes, process for their production and their use in the production of pharmaceuticals |
| 01/30/1991 | EP0410535A2 Octahydrobenzisoquinoline derivatives as antipsychotic agents |
| 01/30/1991 | EP0410517A1 Liquid suspensions of nitrofurantoin |
| 01/30/1991 | EP0410509A1 New substituted 1H-indazole-3-carboxamides |
| 01/30/1991 | EP0410446A1 (S)-5-hydroxydecanoic acid and its therapeutic composition |
| 01/30/1991 | EP0410433A2 Tylosin derivatives |
| 01/30/1991 | EP0410422A2 A highly absorbable pharmaceutical composition |
| 01/30/1991 | EP0410409A1 3,5-Dihydroxypentanoic acid derivatives useful as antihypercholesterolemic agents and method for preparing same |
| 01/30/1991 | EP0410389A1 Indolocarbazol and its use |
| 01/30/1991 | EP0410379A2 Pharmaceutically active 3-aryl and 3-heteroaryl-2-fluoro-1-olefins |
| 01/30/1991 | EP0410366A2 Anthracycline derivatives |
| 01/30/1991 | EP0410359A1 Substituted aminoalkoxy-benzene-derivatives |
| 01/30/1991 | EP0410358A1 Aromatic carboxylic acid amides, their preparation and their use as medicines |
| 01/30/1991 | EP0410348A1 Topical spironolactone composition |
| 01/30/1991 | EP0410343A2 Use of bisphenol derivatives in treating diabetes mellitus |
| 01/30/1991 | EP0410320A1 Process for preparing lankacidine carbamate derivatives |
| 01/30/1991 | EP0410305A2 Use of bis(4-hydroxyphenylthio) methane derivatives in treating diabetes mellitus |
| 01/30/1991 | EP0410278A1 Renin inhibiting aminooligohydroxy-derivatives |
| 01/30/1991 | EP0410260A2 Peptidyl aminodiol renin inhibitors |
| 01/30/1991 | EP0410244A1 Leukotriene antagonists |
| 01/30/1991 | EP0410241A1 Aryl alkenoic acid derivatives as leukotriene antagonists |
| 01/30/1991 | EP0410236A2 Process for the production of carotinoid preparations |
| 01/30/1991 | EP0410224A1 Pyrrolo [2,1-b]thiazole derivatives |
| 01/30/1991 | EP0410208A1 Chroman derivatives |
| 01/30/1991 | EP0410148A1 Novel 5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-ones and thiones and their use in the prevention or treatment of AIDS |
| 01/30/1991 | EP0410147A1 Modified VP1/P2A regions of rhinovirus systems |
| 01/30/1991 | EP0410114A2 Use of 4-[4-(5-fluoro-2-pyrimidinyl)-1-piperazinyl]-1-(4-fluorophenyl)-butanol in pharmaceutical compositions for the treatment of ischemia in brain |
| 01/30/1991 | EP0410099A1 Stable, cosmetically acceptable topical gel formulation and method of treatment for acne |
| 01/30/1991 | EP0409999A1 Liquid preparation for intraocular perfusion |
| 01/30/1991 | EP0409994A1 Active vitamin d for chronic hepatitis treatment |
| 01/30/1991 | EP0409957A1 Biological fluids purification systems |
| 01/30/1991 | EP0409940A1 Methods and compositions for treatment of pathological hydrophobic interactions in biological fluids. |
| 01/30/1991 | EP0409910A1 Laminated composite for transdermal administration of fentanyl. |
| 01/30/1991 | EP0409862A1 Topical preparations. |
| 01/30/1991 | EP0409854A1 Fluorobenzoylpiperidinopropoxymethoxyphenylpyrrolidone effective against obstructive difficulties in urinating |
| 01/30/1991 | EP0409845A1 Method for protection from chemotherapeutic side effects |
| 01/30/1991 | EP0395683A4 Nicotine compositions |
| 01/30/1991 | EP0321548A4 Novel amphiphilic nucleic acid conjugates |
| 01/30/1991 | EP0298121A4 Biocompatible material for treatment of defects in tissues and organs |
| 01/30/1991 | EP0236390B1 Agent against multiple sclerosis |
| 01/30/1991 | EP0216785B1 Indene analogs of mevalonolactone and derivatives thereof |
| 01/30/1991 | CN1048857A Process for preparing 9 alpha-hydroxy-3-oxo-4.24 (25)- stigmastadien-26-oic acid derivatives |